Action

GitLab Faces Securities Class Action: Investors Alerted to Join Lawsuit Over Alleged Misleading AI Development Claims

by

Los Angeles, California – The Schall Law Firm, recognized for representing shareholder rights in national litigation, has recently announced a class action lawsuit targeting GitLab Inc. (NASDAQ: GTLB). The suit accuses the company of violations related to the Securities Exchange Act of 1934, specifically under sections 10(b) and 20(a), along with Rule 10b-5, as put forth by the U.S. Securities and Exchange Commission. This litigation comes following allegations that GitLab disseminated misleading information about its capabilities, particularly concerning its development of artificial intelligence tools aimed at bolstering its DevSecOps platform. The firm prompts investors who … Read more

FTX Settles $228 Million Lawsuit with Bybit, Drops Legal Action in Groundbreaking Agreement

by

In a significant turn of events in the cryptocurrency sector, FTX Trading Ltd. has reached an agreement to settle its legal disputes with competitor Bybit by dropping a lawsuit in exchange for a $228 million settlement. This decision marks an end to the tensions that escalated last March when FTX accused Bybit of infringing on its intellectual property rights by copying the structure and content of its application programming interface, or API. The settlement not only concludes the pending litigation but also introduces a strategic partnership between the two firms. As part of the agreement, … Read more

Rosen Law Firm Announces Key Deadline in Edwards Lifesciences Securities Class Action – Investors Urged to Act by December 13

by

New York — Investors who purchased securities from Edwards Lifesciences Corporation between February 6, 2024, and July 24, 2024, are potentially eligible for compensation, as announced by Rosen Law Firm, a global investor rights legal practice. The firm, which focuses on securities class actions and shareholder derivative litigation, has set a lead plaintiff deadline of December 13, 2024. Anyone who acquired shares in Edwards Lifesciences during the said period might take part in the class action lawsuit without any out-of-pocket fees, as the costs are covered by a contingency fee arrangement. Those interested in joining … Read more

Rosen Law Firm Announces Key Deadline in GitLab Securities Class Action – Investors Urged to Act

by

New York – Investors who have acquired securities from GitLab Inc. are being reminded by the Rosen Law Firm, a global investor rights firm, of an upcoming November 4, 2024 deadline to apply as lead plaintiff in a major class-action lawsuit. This period concerns those who purchased GitLab’s securities between June 6, 2023, and March 4, 2024. Eligible investors might be entitled to compensation facilitated through a contingency fee arrangement requiring no direct out-of-pocket expenses. This lawsuit stems from accusations against GitLab Inc., claiming that executives made false and misleading statements about the company’s ability … Read more